AR008155A1 - Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres. - Google Patents

Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.

Info

Publication number
AR008155A1
AR008155A1 ARP970103968A ARP970103968A AR008155A1 AR 008155 A1 AR008155 A1 AR 008155A1 AR P970103968 A ARP970103968 A AR P970103968A AR P970103968 A ARP970103968 A AR P970103968A AR 008155 A1 AR008155 A1 AR 008155A1
Authority
AR
Argentina
Prior art keywords
compound
formula
women
menopausic
treat
Prior art date
Application number
ARP970103968A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR008155A1 publication Critical patent/AR008155A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ARP970103968A 1996-09-06 1997-08-29 Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres. AR008155A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2543996P 1996-09-06 1996-09-06
US5066697P 1997-06-24 1997-06-24

Publications (1)

Publication Number Publication Date
AR008155A1 true AR008155A1 (es) 1999-12-09

Family

ID=26699738

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970103968A AR008155A1 (es) 1996-09-06 1997-08-29 Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.

Country Status (16)

Country Link
EP (2) EP0927029A4 (fr)
JP (2) JP2002515046A (fr)
KR (2) KR20000068472A (fr)
CN (2) CN1236299A (fr)
AR (1) AR008155A1 (fr)
AU (2) AU4247397A (fr)
BR (2) BR9711676A (fr)
CA (2) CA2264943A1 (fr)
CO (2) CO4920218A1 (fr)
CZ (1) CZ76699A3 (fr)
IL (1) IL128645A0 (fr)
NO (2) NO991097L (fr)
PL (2) PL332278A1 (fr)
TR (2) TR199900504T2 (fr)
TW (1) TW411273B (fr)
WO (2) WO1998009519A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034608A1 (fr) * 1997-02-11 1998-08-13 Novo Nordisk A/S Methodes therapeutiques ou prophylactiques a l'encontre de symptomes menopausiques
GB9827121D0 (en) * 1998-12-09 1999-02-03 Orion Corp Agent for lowering endothelin levels
DE19905961A1 (de) * 1999-02-12 2000-08-17 Stefan Neubauer Verwendung von Östrogenen zur Behandlung der Herzinsuffizienz
US6528681B2 (en) * 2000-04-05 2003-03-04 Bristol-Meyers Squibb Pharma Company Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
TWI303990B (en) 2000-10-17 2008-12-11 Pfizer Prod Inc New use of estrogen agonists/antagonists for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260066B1 (fr) * 1986-09-11 1990-05-09 National Research Development Corporation Dérivés du tamoxifène
DE69316633T2 (de) * 1992-09-15 1998-05-20 Merrell Dow Pharma Nichtmetabolisierbare clomiphene-analoge zur behandlung von tamoxifen-resistenten tumoren
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) * 1994-05-23 1995-11-28 Stromberg; Brent V. Method of treating peripheral vasoconstriction with tamoxifen citrate
JPH11510479A (ja) * 1995-06-07 1999-09-14 ネオルックス コーポレイション タモキシフェン類似体による心臓血管疾病の予防及び治療
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis

Also Published As

Publication number Publication date
KR20000068473A (ko) 2000-11-25
AU4247397A (en) 1998-03-26
NO991096L (no) 1999-03-05
CA2264943A1 (fr) 1998-03-12
PL332038A1 (en) 1999-08-16
NO991097D0 (no) 1999-03-05
TW411273B (en) 2000-11-11
BR9711676A (pt) 1999-08-24
NO991097L (no) 1999-03-05
JP2002515046A (ja) 2002-05-21
TR199900506T2 (xx) 1999-07-21
WO1998009519A1 (fr) 1998-03-12
NO991096D0 (no) 1999-03-05
IL128645A0 (en) 2000-01-31
JP2002515047A (ja) 2002-05-21
AU4409797A (en) 1998-03-26
BR9711681A (pt) 1999-08-24
EP0929216A4 (fr) 2001-04-04
EP0927029A1 (fr) 1999-07-07
CA2264775A1 (fr) 1998-03-12
CZ76699A3 (cs) 1999-08-11
CO4920218A1 (es) 2000-05-29
EP0929216A1 (fr) 1999-07-21
CN1236299A (zh) 1999-11-24
PL332278A1 (en) 1999-08-30
TR199900504T2 (xx) 1999-06-21
EP0927029A4 (fr) 2001-06-13
KR20000068472A (ko) 2000-11-25
CO5070658A1 (es) 2001-08-28
CN1236313A (zh) 1999-11-24
WO1998009619A1 (fr) 1998-03-12

Similar Documents

Publication Publication Date Title
ES2190472T3 (es) Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno.
DE69010336D1 (de) Pharmazeutische zusammensetzung zum abnehmen.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
DE69738615D1 (de) Verwendung von glp-1 oder analogen zur behandlung von myokardischem infarkt
FI970747A (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
MY132705A (en) Novel compounds with analgesic effect
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
EP0350036A3 (fr) Hématoporphyrine pour usage topique
PT1173201E (pt) Metodo para o tratamento de fibrose utilizando um antagonista da subunidade alfa 4 de integrina
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
DE69424777T2 (de) 3,4-diarylchromane zur behandlung von dermatitis
DK0714304T3 (da) Terapeutisk system til behandling af psoriasis
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
EE9800315A (et) Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil
KR910009267A (ko) 우울증의 치료방법
AR003979A1 (es) Administracion transdermica de vorozol.
ES2191206T3 (es) Nueva utilizacion de la creatina.
AR004330A1 (es) Uso de inhibidores de colinesterasa en el tratamiento de xerostomia
DE69729201T2 (de) Sulfonfluoride zur behandlung von der alzheimerischen krankheit
AR012638A1 (es) Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional
MX9301879A (es) Medicamento para el tratamiento de la inflamacion de las vias respiratorias
TR199900013T2 (xx) Yeni bile�ikler.